Experimental designs. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Cells, Circulating Lymphocytes, Tumor-Infiltrating

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Oncolytic Viruses Adenoviridae

Diseases44

Neoplasms Neoplasm Metastasis Breast Neoplasms Lung Neoplasms Disease Progression Prostatic Neoplasms Ovarian Neoplasms Adenocarcinoma Carcinoma, Squamous Cell Melanoma Colorectal Neoplasms Carcinoma Neovascularization, Pathologic Head and Neck Neoplasms Neoplasm Invasiveness Carcinoma, Non-Small-Cell Lung Brain Neoplasms Pancreatic Neoplasms Kidney Neoplasms Lymphatic Metastasis Neoplasms, Experimental Carcinoma, Renal Cell Colonic Neoplasms Recurrence Disease Models, Animal Glioma Glioblastoma Neoplasm Recurrence, Local Liver Neoplasms Urinary Bladder Neoplasms Skin Neoplasms Neoplastic Cells, Circulating Multiple Myeloma Neuroblastoma Neoplasms, Glandular and Epithelial Esophageal Neoplasms Carcinoma, Hepatocellular Cystadenocarcinoma, Serous Adenocarcinoma, Clear Cell Mesothelioma Carcinoma, Pancreatic Ductal Stomach Neoplasms Bone Neoplasms Carcinoma, Endometrioid

Chemicals and Drugs67

Antineoplastic Agents Tumor Markers, Biological Antibodies, Monoclonal RNA, Messenger Quinazolines Receptor, Epidermal Growth Factor Antibodies, Monoclonal, Humanized Cancer Vaccines Receptor, erbB-2 Antigens, Neoplasm Pyrimidines Protein Kinase Inhibitors Ki-67 Antigen Angiogenesis Inhibitors Antineoplastic Agents, Phytogenic Paclitaxel Neoplasm Proteins Piperazines Biomarkers, Pharmacological Vascular Endothelial Growth Factor A Sulfonamides Benzamides Antimetabolites, Antineoplastic Pyrazines Pyrroles Boronic Acids Taxoids Tumor Suppressor Protein p53 DNA, Neoplasm Camptothecin Phenylurea Compounds Proto-Oncogene Proteins B-raf Cisplatin Indoles Niacinamide Enzyme Inhibitors RNA, Neoplasm RNA, Small Interfering Tumor Suppressor Proteins Deoxycytidine Benzenesulfonates Doxorubicin Antineoplastic Agents, Alkylating Hydroxamic Acids Fluorouracil Radiation-Sensitizing Agents Prostate-Specific Antigen Pyridines Receptors, Estrogen Peptides Dacarbazine Carcinoembryonic Antigen Antibiotics, Antineoplastic Proto-Oncogene Proteins c-bcl-2 Pyrazoles Azacitidine Proto-Oncogene Proteins c-akt DNA Primers Antigens, CD31 DNA Modification Methylases Placebos Tamoxifen Thiazoles Proto-Oncogene Proteins Cyclin-Dependent Kinase Inhibitor p16 Antineoplastic Agents, Hormonal HLA-A2 Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment90

Research Design Drug Design Xenograft Model Antitumor Assays Prognosis Immunohistochemistry Treatment Outcome Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Equipment Design Oligonucleotide Array Sequence Analysis Neoplasm Transplantation Maximum Tolerated Dose Blotting, Western Survival Analysis Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Area Under Curve Reproducibility of Results Kaplan-Meier Estimate Transplantation, Heterologous Disease-Free Survival Tissue Array Analysis Tumor Burden Cohort Studies Multivariate Analysis Sensitivity and Specificity Immunoenzyme Techniques Flow Cytometry Immunotherapy Models, Biological Prospective Studies Combined Modality Therapy Models, Statistical Polymerase Chain Reaction Data Interpretation, Statistical Survival Rate Cluster Analysis Follow-Up Studies Drug Administration Schedule Neoplasms, Experimental Inhibitory Concentration 50 Case-Control Studies Administration, Oral In Situ Hybridization, Fluorescence Disease Models, Animal Enzyme-Linked Immunosorbent Assay DNA Mutational Analysis Retrospective Studies Clinical Trials, Phase II as Topic Sample Size Drug Delivery Systems Drug Evaluation, Preclinical Risk Factors Analysis of Variance Prosthesis Design Models, Genetic Pilot Projects Randomized Controlled Trials as Topic Oncolytic Virotherapy Cross-Over Studies Predictive Value of Tests Models, Theoretical Radioimmunotherapy Random Allocation Clinical Trials as Topic Proportional Hazards Models Drug Screening Assays, Antitumor Models, Chemical Clinical Trials, Phase I as Topic Statistics as Topic Technology, Pharmaceutical Positron-Emission Tomography Immunoblotting Regression Analysis Metabolic Clearance Rate Magnetic Resonance Imaging Questionnaires Transfection Double-Blind Method Epidemiologic Research Design Validation Studies as Topic Cross-Sectional Studies Placebos Biopsy Infusions, Intravenous Sequence Analysis, DNA Risk Models, Molecular Protein Array Analysis In Situ Nick-End Labeling

Phenomena and Processes43

Time Factors Gene Expression Regulation, Neoplastic Cell Proliferation Dose-Response Relationship, Drug Drug Resistance, Neoplasm Apoptosis Maximum Tolerated Dose Area Under Curve Mutation Algorithms DNA Methylation Sensitivity and Specificity Drug Synergism Signal Transduction Cell Survival Genotype Inhibitory Concentration 50 Tissue Distribution Phenotype Down-Regulation Cell Cycle Gene Expression Polymorphism, Single Nucleotide Up-Regulation Promoter Regions, Genetic Loss of Heterozygosity Gene Dosage RNA Interference Metabolic Clearance Rate CpG Islands Transfection Cell Division Cell Movement Gene Amplification Microsatellite Repeats Polymorphism, Genetic Phosphorylation DNA Sequence, Unstable Base Sequence Risk Alleles Genetic Vectors Genes, p53

Disciplines and Occupations8

Research Design Drug Design Immunohistochemistry Chemistry, Pharmaceutical Statistics as Topic Technology, Pharmaceutical Computational Biology Proteomics

Technology, Industry, Agriculture1

Technology, Pharmaceutical

Information Science10

Computer-Aided Design Algorithms Computer Simulation Data Interpretation, Statistical Survival Rate Software Software Design Molecular Sequence Data Questionnaires Base Sequence

Health Care37

Treatment Outcome Survival Analysis Area Under Curve Reproducibility of Results Kaplan-Meier Estimate Disease-Free Survival Cohort Studies Multivariate Analysis Sensitivity and Specificity Prospective Studies Models, Statistical Data Interpretation, Statistical Survival Rate Cluster Analysis Follow-Up Studies Case-Control Studies Retrospective Studies Clinical Trials, Phase II as Topic Sample Size Risk Factors Analysis of Variance Pilot Projects Randomized Controlled Trials as Topic Cross-Over Studies Predictive Value of Tests Random Allocation Clinical Trials as Topic Proportional Hazards Models Clinical Trials, Phase I as Topic Statistics as Topic Regression Analysis Questionnaires Double-Blind Method Epidemiologic Research Design Validation Studies as Topic Cross-Sectional Studies Risk

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care Geographicals

Research Design Cell Line, Tumor Drug Design Antineoplastic Agents Xenograft Model Antitumor Assays Mice, Nude Time Factors Prognosis Immunohistochemistry Treatment Outcome Tumor Markers, Biological Gene Expression Regulation, Neoplastic Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Neoplasms Cell Proliferation Dose-Response Relationship, Drug Equipment Design Neoplasm Metastasis Oligonucleotide Array Sequence Analysis Breast Neoplasms Lung Neoplasms Drug Resistance, Neoplasm Apoptosis Disease Progression Neoplasm Transplantation Prostatic Neoplasms Maximum Tolerated Dose Ovarian Neoplasms Computer-Aided Design Blotting, Western Survival Analysis Neoplasm Staging Adenocarcinoma Antibodies, Monoclonal Mice, SCID Antineoplastic Combined Chemotherapy Protocols Area Under Curve Reproducibility of Results Carcinoma, Squamous Cell Melanoma Tumor Cells, Cultured Kaplan-Meier Estimate Colorectal Neoplasms Transplantation, Heterologous Mutation RNA, Messenger Quinazolines Carcinoma Neovascularization, Pathologic Disease-Free Survival Tissue Array Analysis Tumor Burden Head and Neck Neoplasms Algorithms DNA Methylation Cohort Studies Receptor, Epidermal Growth Factor Antibodies, Monoclonal, Humanized Multivariate Analysis Sensitivity and Specificity Immunoenzyme Techniques Neoplasm Invasiveness Cancer Vaccines Receptor, erbB-2 Carcinoma, Non-Small-Cell Lung Antigens, Neoplasm Pyrimidines Brain Neoplasms Pancreatic Neoplasms Computer Simulation Protein Kinase Inhibitors Flow Cytometry Drug Synergism Immunotherapy Ki-67 Antigen Models, Biological Signal Transduction Cell Survival Prospective Studies Combined Modality Therapy Models, Statistical Kidney Neoplasms Polymerase Chain Reaction Angiogenesis Inhibitors Data Interpretation, Statistical Survival Rate Lymphatic Metastasis Cluster Analysis Antineoplastic Agents, Phytogenic Genotype Paclitaxel Follow-Up Studies Drug Administration Schedule Neoplasms, Experimental Inhibitory Concentration 50 Case-Control Studies Administration, Oral Carcinoma, Renal Cell Neoplasm Proteins

No FAQ available that match "experimental designs"